LATE BREAKING ABSTRACT: Docetaxel (Doc) +/- zoledronic acid (ZA) for hormone-naïve prostate cancer: First overall survival results from STAMPEDE &...

Date 27 September 2015
Event European Cancer Congress 2015
Session Genitourinary Malignancies - Prostate and Nonprostate Cancer
Topics Prostate Cancer
Presenter James, N.